Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
61.41
+0.56 (0.92%)
Aug 31, 2026, 4:00 PM EDT - Market closed
Royalty Pharma Market Cap
Royalty Pharma has a market cap or net worth of $35.31 billion as of August 31, 2026. Its market cap has increased by 68.29% in one year.
Market Cap
35.31B
Enterprise Value
43.44B
1-Year Change
68.29%
Ranking
Category
Stock Price
$61.41
ChartMarket Cap Chart
Since June 16, 2020, Royalty Pharma's market cap has increased from $26.49B to $35.31B, an increase of 33.28%. That is a compound annual growth rate of 4.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 31, 2026 | 35.31B | 58.31% |
| Dec 31, 2025 | 22.30B | 48.40% |
| Dec 31, 2024 | 15.03B | -10.44% |
| Dec 29, 2023 | 16.78B | -30.07% |
| Dec 30, 2022 | 24.00B | -0.82% |
| Dec 31, 2021 | 24.20B | -20.37% |
| Dec 31, 2020 | 30.39B | 14.69% |
| Jun 16, 2020 | 26.49B | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 63.60B |
| Moderna | 56.03B |
| Revolution Medicines | 44.06B |
| BeOne Medicines AG | 40.88B |
| Alnylam Pharmaceuticals | 32.21B |
| Insmed | 26.60B |
| BioNTech SE | 25.52B |
| Roivant Sciences | 25.02B |